Alembic Pharmaceuticals Ltd has received four observations from US Food and Drug Administration (FDA) for Panelav facility.
The company stated that US FDA has conducted an inspection at it Panelav facility in Gujarat from 9-13 March, 2020
"None of the observations are related to data integrity or repetitive in nature," the company added.
"The company will provide comprehensive corrective action report to address each observation. The company is committed to maintaining highest quality standards that meet US FDA standards," Alembic Pharma said in BSE filing.